A Phase I Study of Vorinostat in Combination with Idarubicin in Relapsed or Refractory Leukaemia

Histone deacetylase inhibitors (HDACi) affect chromatin remodeling and modulate the expression of aberrantly silenced genes. HDACi have single-agent clinical activity in haematological malignancies and have synergistic anti-leukaemia activity when combined with anthracyclines in vitro. We conducted...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kadia, Tapan M., Yang, Hui, Ferrajoli, Alessandra, Maddipotti, Sirisha, Schroeder, Claudia, Madden, Timothy L., Holleran, Julianne L., Egorin, Merrill J., Ravandi, Farhad, Thomas, Deborah A., Newsome, Willie, Sanchez-Gonzalez, Blanca, Zwiebel, James A., Espinoza-Delgado, Igor, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124904/
https://ncbi.nlm.nih.gov/pubmed/20456355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2010.08211.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller